Cash & Short-Term Investments

$1.36B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$1.36Bperiod endingJun 30, 2026

LGND Quarterly Cash & Short-Term Investments ($2.10M → $1.36B)

Quarterly Cash & Short-Term Investments

High-resolution chart · PNG

LGND cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Cash & Short-Term Investments — Quarterly (USD)
Period ending	Cash & Short-Term Investments (USD)
Jun 30, 2001	45,559,000
Mar 31, 2001	40,885,000
Dec 31, 2000	23,663,000
Sep 30, 2000	31,562,000
Jun 30, 2000	46,492,000
Mar 31, 2000	47,682,000
Dec 31, 1999	47,200,000
Sep 30, 1999	45,800,000
Jun 30, 1999	33,700,000
Mar 31, 1999	46,700,000
Dec 31, 1998	32,800,000
Sep 30, 1998	24,900,000
Jun 30, 1998	25,600,000
Mar 31, 1998	26,100,000
Dec 31, 1997	62,300,000
Sep 30, 1997	13,400,000
Jun 30, 1997	17,700,000
Mar 31, 1997	22,800,000
Dec 31, 1996	34,800,000
Sep 30, 1996	7,000,000
Jun 30, 1996	11,200,000
Mar 31, 1996	16,500,000
Dec 31, 1995	16,000,000
Sep 30, 1995	12,200,000
Mar 31, 1995	13,300,000
Dec 31, 1994	7,600,000
Sep 30, 1994	12,100,000
Jun 30, 1994	700,000
Mar 31, 1994	2,100,000